Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol

Conditions:   COVID-19;   SARS-CoV2 Infection Interventions:   Biological: Ad5-triCoV/Mac;   Biological: ChAd-triCoV/Mac Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials